371
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Drug release from semisolid dosage forms: a comparison of two testing methods

, , , , &
Pages 330-336 | Received 24 Sep 2013, Accepted 06 Nov 2013, Published online: 13 Dec 2013

References

  • Brown CK, Friedel HD, Barker AR, et al. FIP/AAPS Joint Workshop Report: dissolution/in vitro release testing of novel/special dosage forms. Dissolut Technol 2011;18:51–64 and Int J Pharm Sci 2011;73:338–353
  • Ghosal K, Chandra A, Rajabalaya R, et al. Mathematical modelling of drug release profiles for modified hydrophobic HPMC based gels. Pharmazie 2012;67:147–155
  • Barry BW. Drugs and the pharmaceutical sciences: dermatological formulation – percutaneous absorption. New York and Basel: Marcel Dekker; 1983:1--48
  • Corbo M. Techniques for conducting in vitro release studies on semisolid formulations. Dissolut Technol 1995;2:3–6
  • Hanson R, Gray V. Handbook of dissolution testing. 3rd ed. Hockessin (DE): Dissolution Technologies; 2004:33--71
  • Shah VP. IV-IVC for topically applied preparations – a critical evaluation. Eur J Pharm Biopharm 2005;60:309–314
  • Azarmi S, Roa W, Löbenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm 2007;328:12–21
  • Shah VP, Elkins J, Schuirman D, et al. Application of in vitro release methods to assure product performance of semisolid dosage forms before and after certain post-approval changes. Dissolut Technol 1998;5:5–11
  • FDA Guidance for Industry SUPAC-SS. Nonsterile Semisolid Dosage Forms. Scale-up and postapproval changes: chemistry, manufacturing and controls. In vitro release testing and in vivo bioequivalence documentation. U.S. Department of Health and Human Services; Food and Drug Administration, Center for Drug Evaluation and Research, Washington; 2007
  • D’Souza SS, Lozano R, Mayock S, Gray V. AAPS Workshop on the role of dissolution in QbD and drug product life cycle: a commentary. Dissolut Technol 2010;17:41–45
  • Franz T. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 1975;64:190–195
  • Chen L, Fengping T, Wang J, Liu F. Assessment of the percutaneous penetration of indomethacin from soybean oil microemulsion: effects of the HLB value mixed surfactants. Pharmazie 2012;67:31–36
  • Chen L, Fengping T, Wang J, Liu F. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin. Pharmazie 2012;67:319–323
  • Shah VP, Elkins J, Shaw S, Hanson R. In vitro release: comparative evaluation of vertical diffusion cell system and automated procedure. Pharm Dev Technol 2003;8:97–102
  • Sanna V, Peana AT, Moretti MDL. Effect on vehicle on diclofenac sodium penetration from new topical formulations: in vitro and in vivo studies. Curr Drug Deliv 2009;6:93–100
  • Shivhare UD, Jain KB, Mathur VB, et al. Formulation development and evaluation of diclofenac sodium gel using water soluble polyacrylamide polymer. Dig J Nanomater Biostruct 2009;4:285–290
  • Petró É, Balogh Á, Blazsó G, et al. In vitro and in vivo evaluation of drug release from semisolid dosage forms. Pharmazie 2011;66:936–941
  • Hanson R. A primer on release-rate testing of semisolids. Dissolut Technol 2010;17:33–35
  • Katz M, Poulsen BJ. Absorption of drugs through the skin. In: Brodie BB, Gillette J, eds. Handbook of experimental pharmacology. Vol. 28/1. New York: Springer; 1971:103--174
  • Wagner H, Kostka KH, Lehr CM, Schaefer UF. pH profiles in human skin. Influence of two in vitro test systems for drug delivery testing. Eur J Pharm Biopharm 2003;55:57–65
  • Klee SK, Farwick M, Lersch P. Triggered release of sensitive active ingredients upon response to the skin’s natural pH. Coll Surf A Physicochem Eng Aspects 2009;338:162–166
  • Calpena AC, Escribanoaa E, Martinaa HS, et al. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Arzneim-Forsch 1999;49:1012–1017
  • Uslu M, Kilincoglu V, Toker S, et al. Comparison of anti-edema effects of iloprost and diclofenac sodium on traumatic rat paw edema. Acta Orthop Traumatol Turc 2010;44:484–491
  • Chuasuwan B, Binjesoh V, Polli JE, et al. Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium. J Pharm Sci 2009;98:1206–1219
  • Klose D, Delplace C, Siepmann J. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles. Int J Pharmaceutics 2011;404:75–82
  • Escribano E, Cristina CA, Josep Q, et al. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of selected formula. Eur J Pharm Sci 2003;19:203–210
  • Tashtoush BM, Al-Safi SA, Al-Fanek KJ. Azathioprine transport through rat skin and its immunosuppressive effect. Pharmazie 2004;59:143–146
  • Csóka I, Csányi E, Zapantis G, et al. In vitro and in vivo percutaneous absorption of topical dosage forms: case studies. Int J Pharm 2005;291:11–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.